A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation.

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Charlton A, Spence L, Bigley V, Groves N, Hale G, Pagan S, Turner BE, Jones G, Jackson GH, Dickinson AM, Collin M

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: Blood: 51st Annual Meeting of the American Society of Hematology

Year of Conference: 2009

Pages: 1293

ISSN: 0006-4971

Publisher: American Society of Hematology

Library holdings: Search Newcastle University Library for this item

ISBN:

ePrints